Trials / Conditions / Cutaneous Squamous Cell Carcinoma (CSCC)

Cutaneous Squamous Cell Carcinoma (CSCC)

17 registered clinical trials studyying Cutaneous Squamous Cell Carcinoma (CSCC) — 15 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients NCT07286318	Marissa Lobl	EARLY_Phase 1
Not Yet Recruiting	Flash Radiotherapy for Skin Cancer NCT07455331	Jules Bordet Institute	Phase 2
Not Yet Recruiting	Pucotenlimab Combined With Becotatug Vedotin in Advanced Cutaneous Squamous Cell Carcinoma NCT07394244	Fudan University	Phase 2
Not Yet Recruiting	Impact of Preoperative High-Frequency Ultrasound Cutaneous Lesion Extent Assessment on Excision Margin Positiv NCT07361666	Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i Administracji	—
Not Yet Recruiting	A Study of Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Car NCT07100925	Ankyra Therapeutics, Inc	Phase 1
Recruiting	Next-gen Flow Cytometry to Find Immune Profiles, Treatment Response, and Toxicity Markers in Skin Cancer Patie NCT07064330	Instituto de Investigación Biomédica de Salamanca	—
Not Yet Recruiting	MOHs Surgery and Short-Course Radiation Therapy With Structured Follow-Up for Head & Neck Squamous Cell Skin C NCT06998342	University of Vermont Medical Center	Phase 2
Recruiting	Towards Cure Via Only Ultra-short ICB in CSCC NCT06823479	The Netherlands Cancer Institute	Phase 2
Recruiting	Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma NCT06585410	Regeneron Pharmaceuticals	Phase 3
Recruiting	Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers NCT06608511	University of Wisconsin, Madison	—
Not Yet Recruiting	Study of a Strategy Integrating Adjuvant Radiation Therapy Versus Strategy Based on Monitoring in the Treatmen NCT06692556	Centre Leon Berard	Phase 3
Recruiting	A Phase 0 Window of Opportunity Trial of Intratumoral Seasonal Influenza Immunization in Cutaneous Squamous Ce NCT06664151	Dana-Farber Cancer Institute	EARLY_Phase 1
Recruiting	Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma NCT06606028	University of California, San Francisco	—
Recruiting	A Study of VET3-TGI in Patients With Solid Tumors NCT06444815	KaliVir Immunotherapeutics	Phase 1
Recruiting	Usefulness of Post-Operative Radiotherapy in High-grade Cutaneous Squamous Cell Carcinoma: an Observational St NCT06879964	Fondazione IRCCS Policlinico San Matteo di Pavia	—
Active Not Recruiting	Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subj NCT05827614	Boundless Bio, Inc.	Phase 1
Approved For Marketing	Expanded Access Use of Cemiplimab in Patients With Solid Tumors NCT06132191	Regeneron Pharmaceuticals	—